1. Pink Sheet
  2. >>Compliance
  3. >>Manufacturing

FDA Email Alert: Next Day’s Manufacturing Volume Reporting Due Date Still Voluntary

 
• By Bowman Cox and Shannon Brown

Objections to 15 February reporting date established in draft guidance spurred rare last-minute notice assuring industry that it was a non-binding recommendation, not a requirement. Action reflects confusion that can arise in interpreting policy guidance.

When time is melting
when regulatory deadlines melt away • Source: Alamy

The US Food and Drug Administration took the unusual step 14 February of alerting industry by email that a 15 February date for initial pharmaceutical manufacturing volume reports, while recommended, was not required.

Section 3112( e ) of the Coronavirus Aid, Relief and Economic Security (CARES) Act added the reporting requirement to the Food, Drug & Cosmetic Act in a new Section 510(j)(3)....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Manufacturing

More from Compliance